$NBIS

Shtan Danila sold $3.4M of NBIS

Shtan Danila (Chief Technology Officer) sold 14,546 shares of Nebius Group N.V. (NBIS) at $234.16 ($3.41M total) on 2026-10-01.

Original reporting
SEC EDGAR · Shtan Danila
Published Oct 5, 2026, 3:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 3:48 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NBIS
Bearish
medium confidence
Mentioned
$NBIS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NBISBearishLow
01

Why it matters

The disclosed sale adds a modest negative bias to NBIS's short‑term price outlook.

02

Market read

First‑report insider sale; modest size; limited trading relevance.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed.

Relevance 6/10Novelty 4/10Timing: post‑market today

Background

SEC Form 4 filing discloses an insider transaction by Nebius Group's CTO.

Company-level read

Ticker impact

$NBISBearishMedium confidence
Context

CTO Shtan Danila sold 14,546 shares for $3.4M, reducing his stake to 260,217 shares.

Expected impact

likely slight downward pressure as the market prices in the insider sell.

Evidence & confidence

A $3.4M sale by a senior officer is material but not large enough to trigger a major move; traders may watch for further insider activity.

Market effects

Minimal impact on the broader technology sector.

No significant regional effect.

Limited to investors tracking NBIS.

Counterpoint

The sale could be routine portfolio rebalancing, not a bearish signal.

Key entities

  • Nebius Group N.V.

    Issuer of the Form 4 filing.

  • Shtan Danila

    Chief Technology Officer of Nebius Group.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NBISMed

Nebius stock breaks below $200 as CoreWeave’s debt scare spreads

Nebius Group (NBIS) fell 10.1% to $186.01 on October 14, 2026, breaking its $200 support level. The decline was driven by fears of excessive debt in the AI sector, sparked by CoreWeave (CRWV) bonds yielding near 15%. Nebius's funding costs may rise due to this market sentiment. The company's stock trades at 38x trailing sales and 7x forward sales, with analysts' price targets ranging from $84 to $410.

$NBISMed

Why is Nebius stock sliding today?

Nebius Group NV (NBIS) stock fell 4.1% to $178.4 in pre-open trading, extending losses due to rising borrowing costs, higher bond yields for peer CoreWeave, and Gartner's warning about AI infrastructure spending risks. Insider selling and a bearish stance from short-seller Michael Burry also contributed. The broader tech sector selloff, driven by higher Treasury yields, added pressure.

$NBISMed

Nebius Group (NBIS) Shares Drop 10% Amid Tech Sell-Off; P/S Rati

Nebius Group (NBIS) shares fell 10.08% to $186.01 on October 14, 2026, amid a broader tech sector sell-off. The company's P/S ratio is 38.39, significantly above its historical median and industry norms. Nebius has a GF Score of 52, with strong momentum but weak valuation and financial strength. Insiders have sold $318.2 million in shares over the past year, while some institutional investors have increased their stakes.